3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Classical hematology
1
Conditions
Neoplasms
2
Venous Thrombosis
1
Venous Thromboembolism
1
Upper Extremity Deep Vein Thrombosis
1
Recurrence
1
Lung Neoplasms
1
Hemorrhage
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Propofol
6
Carboplatin
5
Sevoflurane
4
Saline Solution
3
Paclitaxel
3
Nivolumab
3
Erlotinib Hydrochloride
3
Acetaminophen
3
Pemetrexed
2
Midazolam
2
Lidocaine
2
Isoflurane
2
Docetaxel
2
Desflurane
2
Cryotherapy
2
Bupivacaine
2
Bronchoscopy
2
Anesthesia, Inhalation
2
trametinib
1
sotorasib
1
pegfilgrastim
1
icotinib
1
endostar protein
1
durvalumab
1
dabrafenib
1
capmatinib
1
camrelizumab
1
beta Carotene
1
atezolizumab
1
alectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Lung Neoplasms
×
Rivaroxaban
×
Clear all
NCT06314763
2024-04-30
ROSIE
Radboud University Medical Center
Phase 4
Completed
21 enrolled